The Cell that Caused Melanoma: Cancer’s Surprise Origins, Caught in Action

This post originally appeared on Vector, Boston Children’s Hospital’s science and clinical innovation blog. It’s long been a mystery why some of our cells can have mutations associated with cancer, yet are not truly cancerous. Now researchers have, for the first time, watched a cancer spread from a single cell in a live animal, and … Read more

What Is CTLA-4 and How Does it Work in Treating Metastatic Melanoma?

Since the early 2000s, when Dana-Farber scientists discovered that many cancer cells carry “checkpoint” proteins that ward off an immune system attack on tumors, a great deal of research has focused on the development and testing of agents capable of blocking those proteins. In many patients, such agents have sent cancers into long-term remissions. A checkpoint … Read more

Remission of Jimmy Carter’s Melanoma Shows Potential of Immunotherapy for Cancer

Former President Jimmy Carter’s announcement earlier this week that he is free of the melanoma that had spread to his liver and brain may be the highest-profile example yet of the promise of a new form of cancer treatment that unleashes an immune system attack on the disease. Carter, 91, was treated with radiation therapy … Read more

Does Having More Moles Increase My Risk of Melanoma?

Moles are benign growths on the skin that sometimes become cancerous. But what exactly is the connection between moles and melanoma, the most aggressive skin cancer? While it’s true that people with many moles should be screened more frequently by a dermatologist, scientists are learning that the mole-melanoma connection isn’t so straightforward. For example, a … Read more

FDA Approves Targeted Therapy Combination for Melanoma

Just over a month after approving a first-of-its-kind combination therapy for advanced melanoma, the U.S. Food and Drug Administration (FDA) has signed off on another drug combination to treat the disease. The FDA has approved a targeted therapy combination, Cotellic (cobimetinib) and vemurafenib, to treat advanced melanoma that has spread to other parts of the … Read more

FDA Approves Immunotherapy Drug Combination for Melanoma

This blog post originally appeared on Cancer Research Catalyst, the official blog of the American Association for Cancer Research. By Karen Honey, PhD Last week, new ground was broken in the field of cancer immunotherapy when the U.S. Food and Drug Administration (FDA) approved the first cancer treatment to combine two of these cutting-edge agents: … Read more

Melanoma – What’s the Latest?

Sun safety applies to everyone, regardless of skin color, gender, or age. That was the message emphasized in a recent live video webchat with Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) dermatologist Jennifer Lin, MD. During the chat, Lin answered questions about the latest in melanoma treatment and prevention. “The bottom line is that UV radiation … Read more

Can Kids Get Melanoma? What Parents Need to Know

Medically reviewed by Carlos Rodriguez-Galindo, MD Although melanoma is more commonly found in adults, childhood and adolescent melanoma affects approximately 300 children in the U.S. each year. Thankfully, the incidence rate has started to decrease in recent years. While melanoma is the least common type of skin cancer in adults, skin cancer in children is almost … Read more

Promising Research Developments Stir Hopes for Melanoma, Lung, Breast and Ovarian Cancer

The growing excitement about the potential of immunotherapy treatments for cancer continued at the 2015 meeting of the American Association for Cancer Research (AACR), one of the largest cancer research meetings of the year. Several Dana-Farber investigators presented encouraging results of immunotherapy for melanoma, lung cancer, and breast cancer. F. Stephen Hodi, MD, and Leena … Read more

How Can Melanoma Affect People of Color?

Melanoma, a type of skin cancer, gets its name from the pigment-producing cells called melanocytes from which tumors can develop. Melanocytes manufacture melanin, a substance in your body that produces hair, eye, and skin pigmentation. Melanin absorbs sunlight and helps to protect skin from DNA damaging ultraviolet light which can contribute to the development of … Read more

Research Report: New Treatments for Melanoma

As recently as five years ago, progress in treating life-threatening malignant melanoma was slow. Since then, several molecularly targeted drugs have burst on the scene, and new strategies for awakening the immune system to attack the cancer cells have yielded dramatic long-term survival benefits for some patients. “The outlook for patients has never been so … Read more

Science Behind Targeted Drug for Pediatric Brain Cancer Has Dana-Farber Roots 

Dana-Farber researcher Charles Stiles, PhD, remembers the call. It was 2008 and a colleague phoned from a conference to deliver the news. Two separate research teams had discovered a genetic driver for the most common of childhood brain tumors called pediatric low-grade glioma. The problem of finding a genetic target to improve treatment for this … Read more